Phacilitate Leaders World 

Features, Workshops & Networking Agenda

Loading

Asia Partnering Lunch

24 Jan 2019
Orchid AB
Asia Hub

An invitation-only event for 40 attendees.Join Phacilitate and Daewoong Pharmaceutical for an intimate networking lunch to learn more about expanding business opportunities in Asia. 

12:30-12:35 Welcome address - Adam Kennedy, Vice President, Morunda 

12:35 - 12:45 - The most suitable mesenchymal stem cell for cell & gene therapeutics - Sung Hyun Choi, Principal Research Scientist, Daewoong Pharmaeutical Co Ltd. 

12:45-12:55 Strategies for commercialization in Asian markets – Gregory A. Bonfiglio, Managing Partner, Proteus LLC

12:55-13:05 Spotlight on Korea David Kim, CEO, Curecell

 

Speakers
Greg Bonfiglio, Founder & Managing Partner - Proteus, LLC
David Kim, CEO - CureCell
Adam Kennedy, Vice President - Morunda
Sung Hyun Choi, Principal Research Scientist - Daewoong Pharmaeutical Co Ltd.
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK